Politics · Singapore Bureau
US blocks Chinese genomics firms over Xinjiang forced labour concerns
The United States has imposed import restrictions on three Chinese genomics companies, citing suspected involvement in forced labour practices in Xinjiang. BGI Group, a leading player in genetic testing, is among the firms targeted by the sanctions.
LSN Singapore ·
The US government has announced a ban on imports from three Chinese genomics companies, escalating tensions over labour practices in China's western Xinjiang region. The restrictions target BGI Group, MGI Tech and Complete Genomics, which the US authorities suspect of processing genetic material from Xinjiang residents as part of surveillance and monitoring programmes.
US officials have raised concerns that the companies are complicit in genetic profiling activities that facilitate mass surveillance in Xinjiang, where international observers have documented widespread rights abuses. The companies' involvement in collecting and analysing genetic data is seen as integral to tracking and controlling the Uyghur and other ethnic minorities in the region.
BGI Group, the world's largest genomics sequencing company, has faced increasing scrutiny from Western governments over its operations and government ties. The company maintains a significant presence across Asia-Pacific and has expanded its COVID-19 testing and other genomic services regionally.
The import ban follows months of heightened US scrutiny of Chinese companies' supply chain practices and forced labour allegations. Washington has progressively tightened restrictions on Chinese firms suspected of links to Xinjiang's security apparatus, citing obligations under US trade law and human rights conventions.